[1]齐晨蕊,杨乐,马彦,等.绝经后2型糖尿病患者瘦素、骨代谢标志物与OP的关系[J].国际内分泌代谢杂志,2024,44(03):177-182.[doi:10.3760/cma.j.cn121383-20231213-12038]
　Qi Chenrui,Yang Le,Ma Yan,et al.Relationship between leptin, bone metabolic markers and OP in postmenopausal patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2024,44(03):177-182.[doi:10.3760/cma.j.cn121383-20231213-12038]
点击复制

绝经后2型糖尿病患者瘦素、骨代谢标志物与OP的关系()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
44
期数:
2024年03期
页码:
177-182
栏目:
论著
出版日期:
2024-05-20

文章信息/Info

Title:
Relationship between leptin, bone metabolic markers and OP in postmenopausal patients with type 2 diabetes mellitus
作者:
齐晨蕊; 杨乐; 马彦; 谢立凯; 关红
吉林省人民医院内分泌代谢病一科,长春 130021
Author(s):
Qi Chenrui;  Yang Le;  Ma Yan;  Xie Likai;  Guan Hong.
Department of Endocrinology and Metabolism,Jilin Provincial People's Hospital, Changchun 130021, China
关键词:
2型糖尿病;  骨质疏松症;  瘦素;  骨代谢标志物
Keywords:
diabetes mellitus type 2;  Osteoporosis;  Leptin;  Bone metabolic markers
DOI:
10.3760/cma.j.cn121383-20231213-12038
摘要:
目的 探析绝经后2型糖尿病(T2DM)患者瘦素、骨代谢标志物与骨质疏松症(OP)的相关性。方法 回顾性纳入2020年1月至2021年12月在我院内分泌科治疗的109例绝经后T2DM患者,并依据骨密度(BMD)测定结果将其分为正常组(n=33)、减少组(n=37)、OP组(n=39)。对比3组患者一般资料及实验室指标差异。采用多因素logistic回归分析确定绝经后T2DM患者发生OP独立危险因素; 并运用Pearson相关性分析瘦素、骨代谢标志物与OP的相关性。结果 OP组甲状腺功能亢进症(以下简称甲亢)患者占比、促甲状腺激素(TSH)、糖化血红蛋白A1c(HbA1c)、瘦素、Ⅰ型胶原羟基端肽(β-CTX)高于正常组与减少组,胰岛素治疗占比、25-羟基维生素D[25(OH)D]、骨钙素、总骨Ⅰ型前胶原N端肽(TPINP)低于正常组与减少组(P<0.05); 多因素logistic回归分析结果显示:甲亢患者、血清瘦素、β-CTX为绝经后T2DM患者发生OP独立危险因素(P<0.05),胰岛素治疗、25(OH)D、骨钙素、TPINP为绝经后T2DM患者发生OP保护因素(P<0.05); Pearson相关性分析显示:血清25(OH)D、骨钙素、TPINP与OP呈正相关(P<0.05); 血清瘦素、β-CTX与OP呈负相关(P<0.05)。结论 瘦素与骨代谢标志物可反映绝经后T2DM患者早期骨代谢情况,预测OP发生风险; 合并甲亢患者、瘦素、β-CTX水平升高、用胰岛素治疗、25(OH)D、骨钙素、TPINP水平降低,可能共同参与绝经后T2DM患者OP发生发展。
Abstract:
Objective To investigate the correlation between leptin(LEP), bone metabolism markers, and osteoporosis(OP)in postmenopausal patients with type 2 diabetes mellitus(T2DM).Methods 109 postmenopausal T2DM patients treated in endocrinology department of our hospital from January 2020 to December 2021 were retrospectively included and divided into normal group(n=33), reduced group(n=37)and OP group(n=39)according to bone mineral density(BMD)measurement results. The differences of general data and laboratory indexes among the three groups were compared. Multivariate logistic regression analysis was used to determine the independent risk factors for OP in postmenopausal T2DM patients. The correlations between LEP, bone metabolism markers and OP were analyzed by Pearson correlation.Results The ratio of hyperthyroidism, thyroid stimulating hormone(TSH), glycosylated hemoglobin(HbA1c), LEP and β-CTX of type I collagen in OP group were higher than those in normal group and reduced group. The proportion of insulin treatment, 25-hydroxyvitamin D[25(OH)D], osteocalcin(BGP)and N-terminal peptide of total bone type I procollagen(TPINP)were lower than those in normal and reduced groups(P<0.05). Multivariate logistic regression analysis showed that hyperthyroidism, serum LEP and β-CTX were independent risk factors for OP in postmenopausal T2DM patients(P<0.05), and insulin therapy, 25(OH)D, BGP and TPINP were protective factors for OP in postmenopausal T2DM patients(P<0.05). Pearson correlation analysis showed that serum 25(OH)D, BGP, TPINP were positively correlated with OP(P<0.05). Serum LEP and β-CTX were negatively correlated with OP(P<0.05).Conclusion LEP and bone metabolism markers can reflect the early bone metabolism of postmenopausal T2DM patients and predict the risk of OP. Combined hyperthyroidism, LEP, β-CTX levels increased, insulin treatment, 25(OH)D, BGP, TPINP levels decreased, which may be involved in the development of OP in postmenopausal T2DM patients.

参考文献/References:

[1] 范晓琳,杨小华,刘月军,等.2型糖尿病性骨质疏松患者骨小梁分数与骨代谢标志物的相关性分析[J].中国骨质疏松杂志,2021,27(11):1599-1602,1613.DOI:10.3969/j.issn.1006-7108.2021.11.008.
[2] Zhang J,Wang C,Yang Z,et al.Correlations of Omentin-1 and Leptin with bone metabolism and plasma glucose upon type 2 diabetes mellitus and osteoporosis[J].Clinical laboratory,2023,69(3):559-564.DOI:10.7754/Clin.Lab.2022.220603.
[3] Mohsin S,Baniyas MM,Aldarmaki RS,et al.An update on therapies for the treatment of diabetes-induced osteoporosis[J].Expert Opin Biol Ther,2019,19(9):937-948.DOI:10.1080/14712598.2019.1618266.
[4] Mori H,Okada Y,Tanaka Y.Incidence of Vitamin D deficiency and its relevance to bone metabolism in Japanese postmenopausal women with type 2 diabetes mellitus[J].Internal Medicine,2015,54(13):1599-1604.DOI:10.2169/internalmedicine.54.3638.
[5] Roebuck G,Mazzolini M,Mohebbi M,et al.Anxiety disorders are associated with reduced bone mineral density in men:findings from the Geelong Osteoporosis study[J].Acta Psychiatrica Scandinavica,2023,148(1):47-59.DOI:10.1111/acps.13563.
[6] 李敏,李辉,刘艳,等.2型糖尿病患者血清甘丙肽及瘦素与冠状动脉粥样硬化性心脏病的相关性研究[J].中国糖尿病杂志,2022,30(12):887-891.DOI:10.3969/j.issn.1006-6187.2022.12.002.
[7] 冯聪,梁琳琅,王卓,等.探讨老年2型糖尿病患者血尿酸水平与骨代谢标志物,骨密度,骨质疏松的相关性[J].检验医学与临床,2022,19(24):3440-3443.DOI:10.3969/j.issn.1672-9455.2022.24.034.
[8] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.DOI:10.3760/cma.j.cn115791-20210221-00095.
[9] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中国骨质疏松杂志,2019,25(3):281-309.DOI:10.3969/j.issn.1006-7108.2019.03.001.
[10] 韩旸,王凯亮,邵楠,等.血清Apelin-13水平与2型糖尿病骨质疏松患者骨代谢相关性研究[J].川北医学院学报,2022,37(9):1124-1126,1130.DOI:10.3969/j.issn.1005-3697.2022.09.006.
[11] Tanaka S,Kobayashi M,Saito K,et al.Impact of denosumab discontinuation on changes in bone mineral density and bone erosion in rheumatoid arthritis patients[J].Mod Rheumatol,2022,32(2):284-291.DOI:10.1093/mr/roab022.
[12] 李冬萍,包小燕,山永仪,等.老年2型糖尿病患者脂质运载蛋白2水平与骨代谢及骨质疏松的相关性研究[J].中国医刊,2021,56(4):391-395.DOI:10.3969/j.issn.1008-1070.2021.04.011.
[13] 程岚,旷劲松,关清华.老年2型糖尿病合并骨质疏松症患者的血清IL-34,APN表达水平与骨代谢标志物的关系[J].标记免疫分析与临床,2021,28(8):1361-1365.DOI:10.11748/bjmy.issn.1006-1703.2021.08.022.
[14] Mohamad,NV,Ima-Nirwana S,Chin KY.Are oxidative stress and inflammation mediators of bone loss due to estrogen deficiency?A review of current evidence[J].Endocr Metab Immune Disord Drug Targets,2020,20(9):1478-1487.DOI:10.2174/1871530320
666200604160614.
[15] Teawtrakul N,Chansai S,Yamsri S,et al.The association of growth differentiation factor-15 levels and osteoporosis in patients with thalassemia[J].Am J Med Sci,2023,366(2):96-101.DOI:10.1016/j.amjms.2023.05.002.
[16] 黄文森,孙志纯,李靖云,等.绝经后女性2型糖尿病患者血清趋化素和骨代谢标志物与骨密度的相关性及其对骨质疏松症的预测价值[J].新乡医学院学报,2022,39(11):1019-1024.DOI:10.7683/xxyxyxb.2022.11.004.

相似文献/References:

[1]曾静波,王姮.2型糖尿病与自身免疫反应[J].国际内分泌代谢杂志,2007,(04):259.
[2]朱素君,谢锦桃,刘军,等.二甲双胍：2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,(04):280.
[3]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
　Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
[4]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
　Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
[5]赵丽娟,徐宽枫,杨涛,等.SLC30A8和PTPRD基因多态性与南京地区中老年人群2型糖尿病的相关性研究[J].国际内分泌代谢杂志,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
　Zhao Lijuan*,Xu Kuanfeng,Yang Tao,et al.Relationship between SLC30A8 and PTPRD gene polymorphisms and type 2 diabetes in middle aged and elderly people in Nanjing area[J].International Journal of Endocrinology and Metabolism,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
[6]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
　Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[7]刘帅,张萍,方毅,等.2型糖尿病合并无症状冠状动脉钙化的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
　Liu Shuai*,Zhang Ping,Fang Yi,et al.Analysis of the risk factors related with asymptomatic coronary calcification for type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
[8]徐庆海,马颖,李铁马.2型糖尿病患者高甘油三酯血症-腰围表型与甲状腺功能异常的关系[J].国际内分泌代谢杂志,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
　Xu Qinghai,Ma Ying,Li Tiema..Association of hypertriglyceridaemic-waist phenotype with thyroid dysfunction in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(03):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
[9]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
　Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(03):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[10]黄桥,白洁,杜洪泉.一种新的脂肪细胞因子——cartonectin[J].国际内分泌代谢杂志,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
　Huang Qiao*,Bai Jie,Du Hongquan..A novel adipokine--cartonectin[J].International Journal of Endocrinology and Metabolism,2015,(03):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]

备注/Memo

备注/Memo:
通信作者:孙亚东,Email:ydsun_2005@163.com
更新日期/Last Update: 2024-05-30